# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 81-90 of 605 results.
PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer .
Status: Not yet recruiting
Last Changed: Jan 11, 2018
First Received: Sep 07, 2017
Disease(s): Ovarian Cancer Stage IV
Intervention(s): Pembrolizumab Injectable Product - Chemotherapy - Bev, Chemotherapy - Bev
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
Status: Recruiting
Last Changed: Feb 20, 2020
First Received: May 14, 2019
Disease(s): Recurrent Ovarian Carcinoma, Platinum-resistant Ovarian Cancer
Intervention(s): ChemoID Assay, Standard Chemotherapy
Locations: Arizona Oncology, Phoenix, Arizona, United States
LSU Health Sciences Center, New Orleans, Louisiana, United States
University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
West Penn Hospital, Allegheny Health Network, Pittsburgh, Pennsylvania, United States
... and 3 other locations.
A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)
Status: Recruiting
Last Changed: Mar 11, 2020
First Received: Jan 12, 2018
Disease(s): Recurrent Platinum Resistant Ovarian Cancer
Intervention(s): VB-111 + Paclitaxel, Placebo + Paclitaxel
Locations: Western Regional Medical Center, Goodyear, Arizona, United States
Arizona Oncology Associates, PC - HAL - USO, Phoenix, Arizona, United States
University of Arizona Cancer Center, Tucson, Arizona, United States
University of Southern California, Los Angeles, California, United States
UCLA-JCCC-Women's Health Clinical Research Unit, Los Angeles, California, United States
... and 58 other locations.
Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer
Status: Recruiting
Last Changed: Mar 10, 2020
First Received: Jan 09, 2018
Disease(s): Ovarian Cancer, Ovarian Neoplasms
Intervention(s): Atezolizumab, Carboplatin, Paclitaxel, Bevacizumab
Locations: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Duke Cancer Institute, Durham, North Carolina, United States
University of Virginia, Charlottesville, Virginia, United States
Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer
Status: Recruiting
Last Changed: Feb 08, 2019
First Received: Jan 19, 2017
Disease(s): Ovarian Cancer, Epithelial
Intervention(s): CC0 - Carboplatin (IV) - Paclitaxel (IV), CC0 - Cisplatin (IP) - Epirubicin (IV), CC>0 - Carboplatin (IV)- Paclitaxel (IV), CC>0 - Cisplatin (IP/IV)- Epirubicin (IV)
Locations: Centre Georges François Leclerc, Dijon, France
Institut Hospitalier Franco-Britannique, Levallois-Perret, France
Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, France
Hôpital Saint Antoine, Paris, France
Hôpital Poissy Saint Germain, Poissy, France
... and 3 other locations.
Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
Status: Recruiting
Last Changed: Oct 08, 2019
First Received: Jul 06, 2018
Disease(s): Ovarian Cancer Stage IV, Ovarian Cancer Stage IIIC, Ovarian Cancer Stage IIIb
Intervention(s): Retarded IDS (Interval Debulking Surgery), Standard IDS (Interval Debulking Surgery)
Locations: ICO Paul Papin, Angers, France
ICA - Polyclinique Urbain V, Avignon, France
Institut Bergonié, Bordeau, France
Hôpital Morvan - Centre Hospitalier Universitaire, Brest, France
Centre François Baclesse, Caen, France
... and 21 other locations.
A Phase 2 Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and TSR-042 in Patients With Platinum Resistant Ovarian Cancer
Status: Recruiting
Last Changed: Jan 13, 2020
First Received: May 20, 2019
Disease(s): Platinum-resistant Ovarian Cancer
Intervention(s): Niraparib, TSR-042
Locations: Mary Bird Perkins, Covington, Louisiana, United States
Chattanooga Program in Women's Oncology, Chattanooga, Tennessee, United States
Diaphragmatic Resection And Gynecological Ovarian Neoplasm
Status: Recruiting
Last Changed: Jun 01, 2018
First Received: Jun 01, 2018
Disease(s): Ovarian Cancer
Intervention(s): thoracic Drain Tube 24 Fr.
Locations: Fondazione Policlinico Agostino Gemelli, Roma, Rome, Italy
Inherited Susceptible Genes Among Epithelial Ovarian Cancer
Status: Recruiting
Last Changed: Nov 14, 2018
First Received: Jan 10, 2017
Disease(s): Ovarian Neoplasm Epithelial, Hereditary Breast and Ovarian Cancer Syndrome
Locations: Lei Li, Beijing, Beijing, China
Peking Union Medical College Hospital, Beijing, Beijing, China
Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer
Status: Recruiting
Last Changed: Jan 21, 2020
First Received: May 20, 2019
Disease(s): Debulking Surgery for Ovarian Cancer
Intervention(s): Ensure Surgery Immunonutrition Shake supplements, Daily Food Intake form
Locations: Memorial Sloan Kettering Cancer Center (Limited Protocol Activities), Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, United States
Memoral Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
... and 3 other locations.